BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18781915)

  • 1. Arylamine N-acetyltransferases in prokaryotic and eukaryotic genomes: a survey of public databases.
    Vagena E; Fakis G; Boukouvala S
    Curr Drug Metab; 2008 Sep; 9(7):628-60. PubMed ID: 18781915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomic and phylogenetic investigation of the xenobiotic metabolizing arylamine N-acetyltransferase enzyme family.
    Glenn AE; Karagianni EP; Ulndreaj A; Boukouvala S
    FEBS Lett; 2010 Jul; 584(14):3158-64. PubMed ID: 20621844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arylamine N-acetyltransferases: what we learn from genes and genomes.
    Boukouvala S; Fakis G
    Drug Metab Rev; 2005; 37(3):511-64. PubMed ID: 16257833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico sequence analysis of arylamine N-acetyltransferases: evidence for an absence of lateral gene transfer from bacteria to vertebrates and first description of paralogs in bacteria.
    Rodrigues-Lima F; Dupret JM
    Biochem Biophys Res Commun; 2002 May; 293(2):783-92. PubMed ID: 12054539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arylamine N-acetyltransferases: a pharmacogenomic approach to drug metabolism and endogenous function.
    Sim E; Pinter K; Mushtaq A; Upton A; Sandy J; Bhakta S; Noble M
    Biochem Soc Trans; 2003 Jun; 31(Pt 3):615-9. PubMed ID: 12773167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.
    Pluvinage B; Dairou J; Possot OM; Martins M; Fouet A; Dupret JM; Rodrigues-Lima F
    Biochemistry; 2007 Jun; 46(23):7069-78. PubMed ID: 17511472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arylamine N-acetyltransferases--from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention.
    Sim E; Fakis G; Laurieri N; Boukouvala S
    Adv Pharmacol; 2012; 63():169-205. PubMed ID: 22776642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arylamine N-acetyltransferases: from structure to function.
    Sim E; Walters K; Boukouvala S
    Drug Metab Rev; 2008; 40(3):479-510. PubMed ID: 18642144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases.
    Brooke EW; Davies SG; Mulvaney AW; Pompeo F; Sim E; Vickers RJ
    Bioorg Med Chem; 2003 Apr; 11(7):1227-34. PubMed ID: 12628650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the genomic and functional divergence of NAT gene family to serve microbial secondary metabolism.
    Boukouvala S; Kontomina E; Olbasalis I; Patriarcheas D; Tzimotoudis D; Arvaniti K; Manolias A; Tsatiri MA; Basdani D; Zekkas S
    Sci Rep; 2024 Jun; 14(1):14905. PubMed ID: 38942826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Investigation of 15 Xenobiotic-Metabolizing
    Garefalaki V; Papavergi MG; Savvidou O; Papanikolaou G; Felföldi T; Márialigeti K; Fakis G; Boukouvala S
    Appl Environ Microbiol; 2021 Sep; 87(19):e0081921. PubMed ID: 34288706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eubacterial arylamine N-acetyltransferases - identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues.
    Payton M; Mushtaq A; Yu TW; Wu LJ; Sinclair J; Sim E
    Microbiology (Reading); 2001 May; 147(Pt 5):1137-1147. PubMed ID: 11320117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics, biochemistry, toxicology, microbiology and cancer research in one go.
    Rodrigues-Lima F; Dairou J; Laurieri N; Busi F; Dupret JM
    Pharmacogenomics; 2011 Aug; 12(8):1091-3. PubMed ID: 21843062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylamine N-acetyltransferases: from drug metabolism and pharmacogenetics to drug discovery.
    Sim E; Abuhammad A; Ryan A
    Br J Pharmacol; 2014 Jun; 171(11):2705-25. PubMed ID: 24467436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and mechanism of arylamine N-acetyltransferases.
    Westwood IM; Kawamura A; Fullam E; Russell AJ; Davies SG; Sim E
    Curr Top Med Chem; 2006; 6(15):1641-54. PubMed ID: 16918475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and structural characterization of the arylamine N-acetyltransferase from the opportunistic pathogen Nocardia farcinica.
    Martins M; Pluvinage B; Li de la Sierra-Gallay I; Barbault F; Dairou J; Dupret JM; Rodrigues-Lima F
    J Mol Biol; 2008 Nov; 383(3):549-60. PubMed ID: 18778714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase.
    Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME
    J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid birth-and-death evolution of the xenobiotic metabolizing NAT gene family in vertebrates with evidence of adaptive selection.
    Sabbagh A; Marin J; Veyssière C; Lecompte E; Boukouvala S; Poloni ES; Darlu P; Crouau-Roy B
    BMC Evol Biol; 2013 Mar; 13():62. PubMed ID: 23497148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomenclature for N-acetyltransferases.
    Vatsis KP; Weber WW; Bell DA; Dupret JM; Evans DA; Grant DM; Hein DW; Lin HJ; Meyer UA; Relling MV
    Pharmacogenetics; 1995 Feb; 5(1):1-17. PubMed ID: 7773298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the phylogeny or arylamine N-acetyltransferases in fungi.
    Martins M; Dairou J; Rodrigues-Lima F; Dupret JM; Silar P
    J Mol Evol; 2010 Aug; 71(2):141-52. PubMed ID: 20676885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.